PDL BioPharma Inc (NASDAQ:PDLI)
| 7.57 Data as of Jan 23 |  -0.02 / -0.26%Today’s Change | 7.16 Today|||52-Week Range 10.26 | -1.82% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 4 2013 | Quarter 1 2014 | Quarter 2 2014 | Quarter 3 2014 | |||
| Revenue and Income | Net Revenues | 110.1M | 139.7M | 164.8M | 165.6M | |
| Depreciation And Amortization | 5.6M | 11.9M | -- | -- | ||
| Operating Expenses | Gross Income | 104.5M | 127.7M | -- | -- | |
| General Expenses | 7.9M | 4.6M | 6.9M | 5.7M | ||
| Total Operating Expenses | 13.5M | 16.5M | 6.9M | 5.7M | ||
| Non-Operating Expenses | Operating Income | 96.6M | 123.2M | 157.9M | 159.9M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 2.0K | ||
| Extraordinary Charge | 0.00 | -6.1M | 0.00 | 0.00 | ||
| Interest Expense On Debt | 6.7M | 10.5M | 9.9M | 9.4M | ||
| Other Expenses | 0.00 | 0.00 | -2.0M | -989.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 97.4M | 115.6M | 146.1M | 149.6M | |
| Income Taxes | -36.4M | -42.7M | -54.0M | -47.4M | ||
| Net Income | 61.1M | 72.9M | 92.1M | 102.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 139.9M | 151.2M | 160.3M | 160.3M | |
| Shares To Calculate EPS Diluted | 158.0M | 164.6M | 177.2M | 166.9M | ||
| Earnings Per Share | EPS | $0.39 | $0.44 | $0.52 | $0.61 | |
| EPS Diluted | $0.39 | $0.44 | $0.52 | $0.61 | ||
.